当前位置:
X-MOL 学术
›
J. Antimicrob. Chemother.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Erratum to: In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from China
Journal of Antimicrobial Chemotherapy ( IF 5.2 ) Pub Date : 2020-04-26 , DOI: 10.1093/jac/dkaa132 Xiaojuan Wang , Chunjiang Zhao , Qi Wang , Zhanwei Wang , Xinyue Liang , Feifei Zhang , Yawei Zhang , Han Meng , Hongbin Chen , Shuguang Li , Chengcheng Zhou , Henan Li , Hui Wang
Journal of Antimicrobial Chemotherapy ( IF 5.2 ) Pub Date : 2020-04-26 , DOI: 10.1093/jac/dkaa132 Xiaojuan Wang , Chunjiang Zhao , Qi Wang , Zhanwei Wang , Xinyue Liang , Feifei Zhang , Yawei Zhang , Han Meng , Hongbin Chen , Shuguang Li , Chengcheng Zhou , Henan Li , Hui Wang
J Antimicrob Chemother 2020; 75: 1850–8
更新日期:2020-06-19